9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Native CRISPR-Cas-Mediated Genome Editing Enables Dissecting and Sensitizing Clinical Multidrug-Resistant P. aeruginosa.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Despite being fundamentally important and having direct therapeutic implications, the functional genomics of the clinical isolates of multidrug-resistant (MDR) pathogens is often impeded by the lack of genome-editing tools. Here, we report the establishment of a highly efficient, in situ genome-editing technique applicable in clinical and environmental isolates of the prototypic MDR pathogen P. aeruginosa by harnessing the endogenous type I-F CRISPR-Cas systems. Using this approach, we generate various reverse mutations in an epidemic MDR genotype, PA154197, and identify underlying resistance mechanisms that involve the extensive synergy among three different resistance determinants. Screening a series of "ancestor" mutant lines uncovers the remarkable sensitivity of the MDR line PA154197 to a class of small, cationic peptidomimetics, which sensitize PA154197 cells to antibiotics by perturbing outer-membrane permeability. These studies provide a framework for molecular genetics and anti-resistance drug discovery for clinically isolated MDR pathogens.

          Related collections

          Author and article information

          Journal
          Cell Rep
          Cell reports
          Elsevier BV
          2211-1247
          November 05 2019
          : 29
          : 6
          Affiliations
          [1 ] School of Biological Sciences, The University of Hong Kong, Pokfulam Road, Hong Kong SAR, China.
          [2 ] State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
          [3 ] CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
          [4 ] Institute of Scientific and Industrial Research, Osaka University, Osaka 567-0047, Japan.
          [5 ] Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
          [6 ] State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China. Electronic address: xiangh@im.ac.cn.
          [7 ] School of Biological Sciences, The University of Hong Kong, Pokfulam Road, Hong Kong SAR, China. Electronic address: ayan8@hku.hk.
          Article
          S2211-1247(19)31299-9
          10.1016/j.celrep.2019.10.006
          31693906
          b58b2b20-ebc7-4aa5-8a09-3a5c727415e2
          History

          native CRISPR-Cas system,multidrug resistance,multidrug efflux pump,genome editing,collateral sensitivity,cationic peptidomimetics,anti-resistance drug discovery,Pseudomonas aeruginosa

          Comments

          Comment on this article